Theravance Biopharma’s latest narrative update has nudged its fair value estimate slightly higher to about $26.71 per share, while the discount rate remains effectively unchanged. This modest shift ...

In this post, I will look at the input and output parameter types for child flows. Recently I hit a couple of small issues ...

Objectives Functional foods have demonstrated potential in preventing gastrointestinal and musculoskeletal (osteo-related) ...